AI
Monday, September 17, 2012 4:41:54 PM
OXGN. OXiGENE Announces Agreement With FDA on Special Protocol Assessment for a Phase 3 Trial of ZYBRESTAT(R) in Anaplastic Thyroid Cancer
http://finance.yahoo.com/news/oxigene-announces-agreement-fda-special-200000396.html
http://finance.yahoo.com/news/oxigene-announces-agreement-fda-special-200000396.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
